Ameritas Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.4M Sell
16,973
-508
-3% -$519K 0.54% 28
2026
Q1
$16.1M Sell
17,481
-192
-1% -$195K 0.49% 28
2025
Q4
$19M Sell
17,673
-1,313
-7% -$1.26M 0.58% 24
2025
Q3
$14.5M Sell
18,986
-737
-4% -$548K 0.44% 28
2025
Q2
$15.4M Sell
19,723
-475
-2% -$369K 0.49% 25
2025
Q1
$16.7M Sell
20,198
-186
-0.9% -$155K 0.57% 23
2024
Q4
$15.7M Sell
20,384
-503
-2% -$416K 0.51% 24
2024
Q3
$18.5M Sell
20,887
-2,113
-9% -$1.9M 0.6% 20
2024
Q2
$20.8M Sell
23,000
-689
-3% -$551K 0.71% 17
2024
Q1
$18.4M Sell
23,689
-669
-3% -$476K 0.63% 17
2023
Q4
$14.2M Sell
24,358
-1,264
-5% -$738K 0.52% 22
2023
Q3
$13.8M Sell
25,622
-2,108
-8% -$1.09M 0.55% 20
2023
Q2
$13M Sell
27,730
-2,900
-9% -$1.22M 0.49% 21
2023
Q1
$10.5M Buy
30,630
+210
+0.7% +$70.8K 0.42% 29
2022
Q4
$10.9M Sell
30,420
-1,765
-5% -$626K 0.44% 27
2022
Q3
$10.4M Sell
32,185
-790
-2% -$250K 0.47% 25
2022
Q2
$10.7M Sell
32,975
-834
-2% -$250K 0.46% 23
2022
Q1
$9.68M Sell
33,809
-339
-1% -$87.2K 0.35% 33
2021
Q4
$9.43M Sell
34,148
-623
-2% -$158K 0.32% 39
2021
Q3
$8.03M Buy
34,771
+388
+1% +$95.8K 0.29% 47
2021
Q2
$7.89M Sell
34,383
-980
-3% -$197K 0.28% 48
2021
Q1
$6.31M Sell
35,363
-569
-2% -$111K 0.24% 56
2020
Q4
$6.07M Sell
35,932
-1,715
-5% -$256K 0.28% 48
2020
Q3
$5.57M Sell
37,647
-1,343
-3% -$208K 0.25% 57
2020
Q2
$6.4M Sell
38,990
-5,358
-12% -$822K 0.3% 46
2020
Q1
$6.15M Sell
44,348
-576
-1% -$79.1K 0.35% 40
2019
Q4
$5.9M Sell
44,924
-2,293
-5% -$266K 0.26% 55
2019
Q3
$5.28M Sell
47,217
-171
-0.4% -$19K 0.24% 58
2019
Q2
$5.25M Sell
47,388
-237
-0.5% -$27.9K 0.24% 58
2019
Q1
$6.18M Sell
47,625
-2,533
-5% -$308K 0.29% 43
2018
Q4
$5.8M Buy
50,158
+3,317
+7% +$371K 0.32% 45
2018
Q3
$5.03M Sell
46,841
-891
-2% -$89.1K 0.23% 59
2018
Q2
$4.07M Sell
47,732
-2,085
-4% -$171K 0.2% 82
2018
Q1
$3.85M Sell
49,817
-5,669
-10% -$456K 0.18% 90
2017
Q4
$4.92M Sell
55,486
-18
-0% -$1.53K 0.22% 70
2017
Q3
$4.65M Sell
55,504
-1,761
-3% -$144K 0.22% 63
2017
Q2
$4.71M Sell
57,265
-361
-0.6% -$29.5K 0.23% 62
2017
Q1
$4.85M Sell
57,626
-3,824
-6% -$306K 0.24% 61
2016
Q4
$4.52M Buy
61,450
+9,517
+18% +$709K 0.23% 70
2016
Q3
$4.17M Sell
51,933
-14,336
-22% -$1.15M 0.23% 64
2016
Q2
$5.22M Buy
66,269
+2,140
+3% +$161K 0.34% 50
2016
Q1
$4.62M Buy
64,129
+10,400
+19% +$787K 0.31% 57
2015
Q4
$4.53M Buy
53,729
+35,320
+192% +$2.93M 0.31% 58
2015
Q3
$1.54M Hold
18,409
0.11% 207
2015
Q2
$1.54M Buy
18,409
+111
+0.6% +$8.46K 0.1% 216
2015
Q1
$1.33M Hold
18,298
0.09% 239
2014
Q4
$1.26M Buy
18,298
+125
+0.7% +$8.44K 0.09% 227
2014
Q3
$1.18M Sell
18,173
-1,083
-6% -$68.6K 0.08% 250
2014
Q2
$1.2M Sell
19,256
-215
-1% -$12.8K 0.09% 251
2014
Q1
$1.15M Sell
19,471
-1,341
-6% -$74.8K 0.09% 260
2013
Q4
$1.06M Sell
20,812
-270
-1% -$13.5K 0.08% 278
2013
Q3
$1.06M Buy
+21,082
New +$1.1M 0.1% 259

Other funds holding LLY

Ameritas Investment Partners's LLY Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Eli Lilly (LLY) stake by 2.9% in Q2 2026, selling an estimated $519K and leaving 16,973 shares worth $20.4M. The position accounts for 0.54% of the portfolio, ranked #28.

Ameritas Investment Partners first reported a position in LLY in Q3 2013 and has held it in 52 quarters since. The position peaked at $20.8M in Q2 2024. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ameritas Investment Partners held 16,973 shares of Eli Lilly worth $20.4M as of Q2 2026.
  • Ameritas Investment Partners sold 508 Eli Lilly shares in Q2 2026, an estimated $519K.
  • Eli Lilly made up 0.54% of Ameritas Investment Partners's portfolio in Q2 2026, its #28 holding.
  • Ameritas Investment Partners first reported a position in Eli Lilly in Q3 2013 and has held it in 52 quarters since.
  • Ameritas Investment Partners's Eli Lilly position peaked at $20.8M in Q2 2024.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.